Rikoon Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$598K Buy
3,203
+2
+0.1% +$391 0.16% 131
2020
Q4
$541K Sell
3,201
-124
-4% -$18.5K 0.15% 133
2020
Q3
$492K Sell
3,325
-37
-1% -$5.73K 0.15% 125
2020
Q2
$552K Sell
3,362
-998
-23% -$153K 0.18% 107
2020
Q1
$605K Buy
4,360
+1
+0% +$137 0.25% 94
2019
Q4
$573K Buy
4,359
+2
+0% +$232 0.2% 115
2019
Q3
$487K Buy
4,357
+1
+0% +$111 0.18% 120
2019
Q2
$483K Buy
4,356
+2
+0% +$236 0.18% 118
2019
Q1
$565K Hold
4,354
0.21% 112
2018
Q4
$504K Hold
4,354
0.21% 112
2018
Q3
$467K Sell
4,354
-20
-0.5% -$2K 0.17% 126
2018
Q2
$373K Buy
4,374
+100
+2% +$8.21K 0.14% 146
2018
Q1
$323K Buy
4,274
+999
+31% +$80.4K 0.13% 150
2017
Q4
$277K Hold
3,275
0.11% 148
2017
Q3
$280K Hold
3,275
0.12% 139
2017
Q2
$269K Hold
3,275
0.12% 140
2017
Q1
$269K Buy
3,275
+600
+22% +$48.1K 0.12% 144
2016
Q4
$208K Buy
+2,675
New +$199K 0.09% 162

Other funds holding LLY

Rikoon Group's LLY Position: Q1 2021 in Review

Rikoon Group increased its Eli Lilly (LLY) stake by 0.06% in Q1 2021, buying an estimated $391 and bringing the position to 3,203 shares worth $598K. The position accounts for 0.16% of the portfolio, ranked #131.

Rikoon Group first reported a position in LLY in Q4 2016 and has held it in 18 quarters since. The position peaked at $605K in Q1 2020. 1,949 funds tracked by Wall St. Rank hold LLY as of Q1 2021.

  • Rikoon Group held 3,203 shares of Eli Lilly worth $598K as of Q1 2021.
  • Rikoon Group bought 2 Eli Lilly shares in Q1 2021, an estimated $391.
  • Eli Lilly made up 0.16% of Rikoon Group's portfolio in Q1 2021, its #131 holding.
  • Rikoon Group first reported a position in Eli Lilly in Q4 2016 and has held it in 18 quarters since.
  • Rikoon Group's Eli Lilly position peaked at $605K in Q1 2020.
  • 1,949 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.